chrX-51743886-G-A
Variant summary
Our verdict is Benign. Variant got -8 ACMG points: 0P and 8B. BP4_StrongBS2
The NM_018094.5(GSPT2):c.260G>A(p.Gly87Asp) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000166 in 1,203,769 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 8 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. 13/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_018094.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -8 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
GSPT2 | NM_018094.5 | c.260G>A | p.Gly87Asp | missense_variant | 1/1 | ENST00000340438.6 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
GSPT2 | ENST00000340438.6 | c.260G>A | p.Gly87Asp | missense_variant | 1/1 | NM_018094.5 | P1 |
Frequencies
GnomAD3 genomes AF: 0.0000622 AC: 7AN: 112586Hom.: 0 Cov.: 23 AF XY: 0.000144 AC XY: 5AN XY: 34742
GnomAD3 exomes AF: 0.0000367 AC: 6AN: 163673Hom.: 0 AF XY: 0.0000190 AC XY: 1AN XY: 52739
GnomAD4 exome AF: 0.0000119 AC: 13AN: 1091183Hom.: 0 Cov.: 32 AF XY: 0.00000839 AC XY: 3AN XY: 357723
GnomAD4 genome AF: 0.0000622 AC: 7AN: 112586Hom.: 0 Cov.: 23 AF XY: 0.000144 AC XY: 5AN XY: 34742
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jan 23, 2023 | The c.260G>A (p.G87D) alteration is located in exon 1 (coding exon 1) of the GSPT2 gene. This alteration results from a G to A substitution at nucleotide position 260, causing the glycine (G) at amino acid position 87 to be replaced by an aspartic acid (D). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at